he prevention, diagnosis, and management of ovarian diseases especially neoplastic lesions continue to challenge clinicians caring for women of all ages. The medical community and the public are well aware of the high mortality rate associated with the diagnosis of epithelial ovarian carcinoma and that it is responsible for approximately 15,000 deaths annually in the United States of America.1 Although, there has been tremendous improvement in the survival rate of young women with germ cell ovarian malignancies, the same has not been true for women with epithelial ovarian carcinoma. The most important positive prognosticator for improved survival of patients with ovarian carcinoma is diagnosis at an early stage. For this reason, significant...
We analyzed New South Wales Central Cancer Registry data for 1980-2003, to determine time trends in ...
Copyright to Australian Family Physician. Reproduced with permission. Permission to reproduce must b...
Ovarian cancer patients who carry germ-line BRCA1 mutations may have improved survival compared with...
Vol. 4 No.2 co nt in ui ng educationfor n ursing I n T h i s I s s u e O varian cancer has been call...
Ovarian malignancy is a serious disease affecting women of all ages, more so above 50 years, and the...
Ovarian carcinoma is the fifth common cause of cancer death among women in Malaysia, with five-year ...
Ovarian cancer is a complex disease, mostly observed in postmenopausal women, and is associated with...
Ovarian Cancer is the fifth leading cause of death in women in the United States and the most com-mo...
There are approximately 22,200 new cases of ovarian cancer (OC) within the US each year. The overall...
To establish the relative frequency, age distribution, socio-demographic risk factors, clinical pres...
The epithelial ovarian cancer (EOC) has been underdiagnosed because it does not have a specific clin...
Ovarian cysts and tumours are a relatively common finding among women of many ages, particularly wit...
Identifying, understanding, and curing disease is a lifelong endeavor for any medical practitioner. ...
Objective: To identify early warning signs and symptoms of ovarian cancer to create awareness for ea...
Ovarian cancer is the seventh most common cancer in women worldwide, with 239 000 new cases diagnose...
We analyzed New South Wales Central Cancer Registry data for 1980-2003, to determine time trends in ...
Copyright to Australian Family Physician. Reproduced with permission. Permission to reproduce must b...
Ovarian cancer patients who carry germ-line BRCA1 mutations may have improved survival compared with...
Vol. 4 No.2 co nt in ui ng educationfor n ursing I n T h i s I s s u e O varian cancer has been call...
Ovarian malignancy is a serious disease affecting women of all ages, more so above 50 years, and the...
Ovarian carcinoma is the fifth common cause of cancer death among women in Malaysia, with five-year ...
Ovarian cancer is a complex disease, mostly observed in postmenopausal women, and is associated with...
Ovarian Cancer is the fifth leading cause of death in women in the United States and the most com-mo...
There are approximately 22,200 new cases of ovarian cancer (OC) within the US each year. The overall...
To establish the relative frequency, age distribution, socio-demographic risk factors, clinical pres...
The epithelial ovarian cancer (EOC) has been underdiagnosed because it does not have a specific clin...
Ovarian cysts and tumours are a relatively common finding among women of many ages, particularly wit...
Identifying, understanding, and curing disease is a lifelong endeavor for any medical practitioner. ...
Objective: To identify early warning signs and symptoms of ovarian cancer to create awareness for ea...
Ovarian cancer is the seventh most common cancer in women worldwide, with 239 000 new cases diagnose...
We analyzed New South Wales Central Cancer Registry data for 1980-2003, to determine time trends in ...
Copyright to Australian Family Physician. Reproduced with permission. Permission to reproduce must b...
Ovarian cancer patients who carry germ-line BRCA1 mutations may have improved survival compared with...